Generic Exclusivity Forfeiture Provision Hits Snag In Courts; FTC Wants Fix
Executive Summary
A key provision of the Medicare Modernization Act's forfeiture provision for ANDA filers' 180-day exclusivity could be moot if courts continue to refuse to hear petitions by generic companies for declaratory judgments
You may also be interested in...
House Bill Banning “Reverse Settlements” Would Give FTC Exemption Power
A bill introduced by Rep. Bobby Rush, D-Ill., banning "reverse" settlements between brand and generic companies would give the Federal Trade Commission the power to allow any such agreement it deems furthers market competition
House Bill Banning “Reverse Settlements” Would Give FTC Exemption Power
A bill introduced by Rep. Bobby Rush, D-Ill., banning "reverse" settlements between brand and generic companies would give the Federal Trade Commission the power to allow any such agreement it deems furthers market competition
Declaratory Judgments For Generic Firms May Be Easier After MedImmune Case
The first application of a recent Supreme Court decision which appears to ease the way for declaratory judgment actions by ANDA filers could be in a case brought by Teva against Novartis regarding Famvir